BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 8:43:38 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-10-20 00:20 |
|
Peer-Review Started |
|
2025-10-21 08:06 |
|
First Decision by Editorial Office Director |
|
2025-11-18 07:48 |
|
Return for Revision |
|
2025-11-18 07:48 |
|
Revised |
|
2025-11-26 04:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-29 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-30 06:13 |
|
Articles in Press |
|
2025-12-30 06:13 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-27 06:27 |
|
Publish the Manuscript Online |
|
2026-02-06 08:43 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abul Bashar Mohammad Kamrul-Hasan, Shehla Shaikh, Hamid Ashraf, Mohammad Shafi Kuchay, Lakshmi Nagendra, Deep Dutta and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abul Bashar Mohammad Kamrul-Hasan, Assistant Professor, Department of Endocrinology, Mymensingh Medical College, Mymensingh Sadar, Mymensingh 2200, Bangladesh. rangassmc@gmail.com |
| Key Words |
Type 2 diabetes; Sodium-glucose cotransporter-2 inhibitors; Ramadan; Religious fasting; Safety; Meta-analysis |
| Core Tip |
This meta-analysis assessed the safety and effectiveness of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in adults with type 2 diabetes fasting during Ramadan. Among 12 studies with 3625 participants, SGLT2i increased risks of postural dizziness, hypotension, and sodium loss, but achieved greater reductions in blood pressure and a lower risk of symptomatic hypoglycemia than other glucose-lowering drugs. SGLT2i did not impact glycemic control, body weight, or renal function. Other adverse events, like dehydration and severe hypoglycemia, showed no significant difference. SGLT2i appear safe and effective for diabetes management during Ramadan fasting, but larger studies are needed to confirm safety for vulnerable groups. |
| Publish Date |
2026-02-06 08:43 |
| Citation |
Kamrul-Hasan ABM, Shaikh S, Ashraf H, Kuchay MS, Nagendra L, Dutta D, Pappachan JM. Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis. World J Diabetes 2026; 17(2): 115495 |
| URL |
https://www.wjgnet.com/1948-9358/full/v17/i2/115495.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v17.i2.115495 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
